Lataa...
Epistatic connectivity among hepatitis C virus genomic sites as genetic marker of interferon resistance
The current standard-of-care therapy of patients with hepatitis C virus (HCV) infection involves treatment with interferon (IFN) and ribavirin. Host demographic and genetic factors as well as HCV genetic heterogeneity were shown to be associated with outcomes of therapy. Although resistance to IFN/R...
Tallennettuna:
| Julkaisussa: | Antivir Ther |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5762110/ https://ncbi.nlm.nih.gov/pubmed/23321567 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3851/IMP2478 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|